Differential Expression and Utilisation of CD34, EMA, PR, and Inhibin in Differentiating Meningioma, Haemangioblastoma, and Solitary Fibrous Tumour: A Cross-sectional Study

Author:

Nakhro Nuneno,Agrawal Meetu,Gupta Snigdha,Ahuja Sana,Shankar Kepeemadam Balasubramanyam,Ranga Sunil

Abstract

Introduction: Mesenchymal tumours of the Central Nervous System (CNS) include meningioma, haemangioblastoma, and Solitary Fibrous Tumour (SFT). Although conventional histopathological examination remains the mainstay in diagnosis, Immunohistochemistry (IHC) plays an important role in CNS tumours, owing to its diagnostic significance and prognostic implications. Aim: To evaluate whether combined use of inhibin, Epithelial Membrane Antigen (EMA,) Progesterone Receptor (PR) and CD34 improves diagnostic accuracy in meningeal and non meningeal mesenchymal tumours of CNS. Materials and Methods: This was a cross-sectional retrospective observational study conducted in the Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India, October 2022 to December 2022 in which all brain tumour specimens diagnosed as meningeal or non meningeal mesenchymal tumours from January 2022 to August 2022 were included in the present study. Sections were immunostained with an IHC panel of EMA, PR, inhibin, CD34, and Ki67. The immunohistochemical expression of EMA, PR, inhibin, and CD34 was expressed as frequencies and percentages, along with sensitivity and diagnostic accuracy evaluation. Ki67 was assessed in the hotspots and expressed as a percentage. The data were presented as frequencies and percentages. Results: A total of 60 patients were included, with an age range from 12 to 73 years and a mean age of 48.2 years. Female predominance, constituted 40 (67.5%) of the study population. Out of the total cases, 49 (81.7%), 9 (15%), and 2 (3.3%) cases were of meningioma, haemangioblastoma, and SFTs, respectively. Among the 49 cases of meningioma, the majority 47 (96%) showed diffuse and strong staining for EMA with a cytoplasmic staining pattern±membranous accentuation. PR was expressed in 45 (92%) of the meningiomas. Inhibin was diffusely expressed in stromal cells of haemangioblastoma 9 (100%). A characteristic cytoplasmic positivity of CD34 was observed in both cases 2 (100%) of SFT. The Ki67 index of anaplastic and atypical meningiomas was 15%, while all other tumours had a very low proliferation index of 2%. Conclusion: The IHC panel comprising CD34, EMA, and inhibin was useful in the differential diagnosis of both meningeal and non meningeal mesenchymal tumours in the CNS, even in cases with overlapping histomorphological features. Inhibin had a very high sensitivity and diagnostic accuracy for the diagnosis of haemangioblastomas. EMA and PR also had fairly good sensitivity and diagnostic accuracy for the diagnosis of meningiomas. CD34 had good sensitivity but very poor diagnostic accuracy for the diagnosis of SFT.

Publisher

JCDR Research and Publications

Subject

Clinical Biochemistry,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3